These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9823958)

  • 1. Rearranged immunoglobulin light chain genes as minimal residual disease markers in intermediate- and high-grade malignant B cell non-Hodgkin's lymphoma.
    Hoogeveen-Westerveld M; Hupkes PE; Doekharan D; Dorssers LC; van't Veer MB; van Belzen N
    Leukemia; 1998 Nov; 12(11):1810-6. PubMed ID: 9823958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of minimal disease using rearranged immunoglobulin heavy chain genes from intermediate- and high-grade malignant B cell non-Hodgkins lymphoma.
    van Belzen N; Hupkes PE; Doekharan D; Hoogeveen-Westerveld M; Dorssers LC; van't Veer MB
    Leukemia; 1997 Oct; 11(10):1742-52. PubMed ID: 9324296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation.
    Zwicky CS; Maddocks AB; Andersen N; Gribben JG
    Blood; 1996 Nov; 88(9):3314-22. PubMed ID: 8896395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymerase chain reaction screening of immunoglobulin heavy chain and T cell receptor gamma gene rearrangements: a practical approach to molecular DNA analysis of non-Hodgkin's lymphoma in a surgical pathology laboratory.
    Hayashi Y; Fukayama M; Funata N; Hishima T; Oba T; Koike M
    Pathol Int; 1999 Feb; 49(2):110-7. PubMed ID: 10355963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
    Chan DW; Liang R; Kwong YL; Chan V
    Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas.
    Pott C; Tiemann M; Linke B; Ott MM; von Hofen M; Bolz I; Hiddemann W; Parwaresch R; Kneba M
    Leukemia; 1998 Oct; 12(10):1630-7. PubMed ID: 9766510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of bone marrow cells in non-Hodgkin's lymphoma by DNA analysis.
    Chen PM; Fan S; Lin SH; Tzeng CH; Liu JH; Liu JM; Yeh HM; Chiou TJ
    Leuk Res; 1991; 15(12):1097-106. PubMed ID: 1662735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRD Detection in B-Cell Non-Hodgkin Lymphomas Using Ig Gene Rearrangements and Chromosomal Translocations as Targets for Real-Time Quantitative PCR.
    Pott C; Brüggemann M; Ritgen M; van der Velden VHJ; van Dongen JJM; Kneba M
    Methods Mol Biol; 2019; 1956():199-228. PubMed ID: 30779036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCR-based assays for the detection of monoclonality in non-Hodgkin's lymphoma: application to formalin-fixed, paraffin-embedded tissue and decalcified bone marrow samples.
    Weirich G; Funk A; Hoepner I; Heider U; Noll S; Pütz B; Fellbaum C; Höfler H
    J Mol Med (Berl); 1995 May; 73(5):235-41. PubMed ID: 7670927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Detection of minimal residual diseases in B-cell tumors using PCR specific for the immunoglobulin heavy chain gene].
    Matolcsy A; Borbényi Z; Demeter J; Egyed M; Fekete S; Földi J; Gergely L; Kajtár P; Kelényi G; Kiss A; László T; Lehoczky D; Losonczy H; Nagy M; Pál K; Pálóczy K; Radványi G; Semsei I; Varga G; Udvardy M
    Orv Hetil; 2000 Jun; 141(25):1403-6. PubMed ID: 10934884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin light chain gene translocations in non-Hodgkin's lymphoma as assessed by fluorescence in situ hybridisation.
    Fujimoto Y; Nomura K; Fukada S; Shimizu D; Shimura K; Matsumoto Y; Horiike S; Nishida K; Shimazaki C; Abe M; Taniwaki M
    Eur J Haematol; 2008 Feb; 80(2):143-50. PubMed ID: 18005388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of immunologic purging in mantle cell lymphoma assessed by polymerase chain reaction detection of minimal residual disease.
    Andersen NS; Donovan JW; Borus JS; Poor CM; Neuberg D; Aster JC; Nadler LM; Freedman AS; Gribben JG
    Blood; 1997 Nov; 90(10):4212-21. PubMed ID: 9354694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel diagnostic biomarker for patients with Non-Hodgkin's Lymphoma by IgH gene rearrangement.
    Bo J; Sun L; Wang W; Ma C; Li H; Zhao Y
    J Cancer Res Ther; 2016; 12(2):903-8. PubMed ID: 27461672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of immunoglobulin and T-cell receptor gene rearrangements in patients with non-Hodgkin's lymphoma].
    Wu RQ; Qiao C; Tong Y; Ge Z; Zhang JF; Wu YJ; Qiu HR; Wang Z; Liu P
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):10-5. PubMed ID: 22575185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automated high resolution PCR fragment analysis for identification of clonally rearranged immunoglobulin heavy chain genes.
    Linke B; Bolz I; Fayyazi A; von Hofen M; Pott C; Bertram J; Hiddemann W; Kneba M
    Leukemia; 1997 Jul; 11(7):1055-62. PubMed ID: 9204991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [BCL-2/IgH and IgH gene rearrangements in bone marrow mononuclear cells of patients with non-Hodgkin's lymphoma].
    Zhang XH; Liang Y; Wang GJ; Ruan EB; Fu R; Qu W; Liu H; Guan J; Song J; Wang HQ; Wu YH; Xing LM; Wang XM; Wang J; Li LJ; Shao ZH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Apr; 19(2):379-84. PubMed ID: 21518492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection and significance of chromosome abnormalities in patients with malignant non-Hodgkin's lymphoma using the polymerase chain reaction].
    Janda J; Benesová E; Slavícková A; Klener P
    Cas Lek Cesk; 1999 Jan; 138(2):47-51. PubMed ID: 10376403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult lymphoma cells prevalent in autologous marrow from non-Hodgkin's diffuse lymphoma.
    Yokoyama J; Fujimiya Y; Yamaguchi T; Shiga K; Saijo Y; Groveman DS; McBain JA; Suzuki Y; Ebina T
    Am J Hematol; 2003 May; 73(1):1-11. PubMed ID: 12701113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of minimal residual disease by polymerase chain reaction in B cell malignancies.
    Moos M; Schulz R; Cremer F; Sucker C; Schmohl D; Döhner H; Goldschmidt H; Haas R; Hunstein W
    Stem Cells; 1995 Dec; 13 Suppl 3():42-51. PubMed ID: 8747988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heteroduplex analysis of VDJ amplified segments from rearranged IgH genes for clonality assessments in B-cell non-Hodgkin's lymphoma. A comparison between different strategies.
    González M; González D; López-Pérez R; García-Sanz R; Chillón MC; Balanzategui A; Mateos MV; Alaejos I; Langerak AW; Orfão A; Van Dongen JJ; San Miguel JF
    Haematologica; 1999 Sep; 84(9):779-84. PubMed ID: 10477449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.